A new method for separating cells to improve cancer treatment and research.
Official title: Simple and Effective Method for Cell Separation During Preclinical Research and Cell Therapy Manufacturing
Funded at Proteios Technology, INC. · NIH-10676986 · Data updated 2026-11-12
This study is working on a new, affordable way to separate specific types of cells that can help researchers create better treatments for cancer and other serious illnesses, making it easier for patients to access these advanced therapies.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Proteios Technology, INC. NIH-funded |
| Lab location | 1 site (Issaquah, United States) |
| Project start | September 1, 2019 |
| Project end | July 31, 2025 |
| Funding year | 2023 |
| Award (this year) | $778,695 |
| NIH project number | 5R44GM134729-03 |
| Project ID | NIH-10676986 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals with cancers or other conditions that may benefit from advanced cell therapies.
✕Less likely to help
Patients who do not have access to or require cell therapies may not receive direct benefits from this research.
What this research studies
This research focuses on developing a cost-effective and efficient cell separation technology that can be used in preclinical research and the manufacturing of cell therapies. By isolating specific cell subpopulations, the technology aims to enhance the study and application of these cells in treating various cancers and other serious diseases. The project will create specialized cartridges for a cell therapy manufacturing instrument, making it easier for researchers to access and utilize these advanced therapies. Patients may benefit from improved access to effective cell therapies as a result of this innovation.
Why it matters
Potential benefit: If successful, this research could significantly lower the costs and improve the accessibility of life-saving cell therapies for patients.
How similar studies have gone: Other research has shown promise in developing cell separation technologies, indicating that this approach could lead to significant advancements in the field.
Where this research is happening
-
Proteios Technology, INC.
Issaquah, United States Active
Researchers
- Principal investigator: Snyder, Bob — Proteios Technology, INC.
- Study coordinator: Snyder, Bob
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.